(GOG 0261) A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel in Chemotherapy -Naive Patients With Newly Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus, Fallopian Tube, Peritoneum or Ovary
Description: 

To determine if treatment with combination paclitaxel and carboplatin (TC) chemotherapy does not result in an inferior death rate when compared to ifosfamide, mesna, and paclitaxel chemotherapy. To bank formalin-fixed and paraffin-embedded (FFPE) tumor tissue and DNA extracted from whole blood specimen for future research.

Study Number: 

NCG 215112

Phase: 
III
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT00954174

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.